NSAID-induced gastrointestinal and cardiovascular injury
- 1 November 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Gastroenterology
- Vol. 26 (6) , 611-617
Abstract
To review recent publications related to NSAID-induced adverse effects on the gastrointestinal and cardiovascular systems. This paper explores novel mechanisms of NSAID-induced gastrointestinal injury, highlights new composite endpoints evaluating adverse events of NSAIDs in the entire gastrointestinal tract, and combines published data to establish evidence-based guidance on the best use of NSAIDs to achieve optimal clinical outcomes whilst minimizing cardiovascular and gastrointestinal injuries. NSAIDs can induce peptic ulcers via epithelial cell membrane disruption and the renin angiotensin system, independent of the cyclooxygenase (COX) pathways, whereas mast cells and bile acid sensors may have a protective effect on NSAID-induced gastrointestinal damage. Patients with arthritis treated with a COX-2 inhibitor are less likely to develop upper and lower gastrointestinal complications than those who are treated with diclofenac plus a proton pump inhibitor (PPI). PPI therapy is recommended in patients receiving dual antiplatelet treatment but observational studies show that clopidogrel users taking PPIs have an increased risk of cardiovascular events. Until further reliable controlled data are available, this potential, but currently unproven, clinical interaction can be minimized by widely separating the dosing of clopidogrel and PPI. Histamine-2 antagonists may be an alternative to PPI for the prevention of peptic ulcers in patients taking low-dose aspirin.Keywords
This publication has 43 references indexed in Scilit:
- Predictors of gastroduodenal erosions in patients taking low‐dose aspirinAlimentary Pharmacology & Therapeutics, 2009
- Meta‐analysis: incidence of endoscopic gastric and duodenal ulcers in placebo arms of randomized placebo‐controlled NSAID trialsAlimentary Pharmacology & Therapeutics, 2009
- A population-based study of the drug interaction between proton pump inhibitors and clopidogrelCanadian Medical Association Journal, 2009
- Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study)Rheumatology, 2009
- Genetic Determinants of Response to Clopidogrel and Cardiovascular EventsNew England Journal of Medicine, 2009
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyThe Lancet, 2009
- Guidelines of Prevention and Treatment for NSAID-related Peptic UlcersThe Korean Journal of Gastroenterology, 2009
- Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled TrialsCirculation, 2008
- Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over studyJournal of Gastroenterology, 2008
- Serious lower gastrointestinal clinical events with nonselective NSAID or coxib useGastroenterology, 2003